A detailed history of Silverarc Capital Management, LLC transactions in Cerus Corp stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 1,495,329 shares of CERS stock, worth $2.36 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
1,495,329
Previous 1,465,744 2.02%
Holding current value
$2.36 Million
Previous $2.58 Million 0.85%
% of portfolio
0.65%
Previous 0.73%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.7 - $2.39 $50,294 - $70,708
29,585 Added 2.02%
1,495,329 $2.6 Million
Q1 2024

May 14, 2024

SELL
$1.66 - $2.42 $56,617 - $82,538
-34,107 Reduced 2.27%
1,465,744 $2.77 Million
Q4 2023

Feb 14, 2024

BUY
$1.25 - $2.35 $369,951 - $695,508
295,961 Added 24.58%
1,499,851 $3.24 Million
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.07 $68,437 - $140,068
45,625 Added 3.94%
1,203,890 $1.95 Million
Q2 2023

Aug 14, 2023

BUY
$1.79 - $2.9 $9,599 - $15,552
5,363 Added 0.47%
1,158,265 $2.85 Million
Q1 2023

May 15, 2023

SELL
$2.65 - $3.81 $1.27 Million - $1.83 Million
-481,112 Reduced 29.44%
1,152,902 $3.42 Million
Q4 2022

Feb 14, 2023

BUY
$3.38 - $4.22 $59,335 - $74,082
17,555 Added 1.09%
1,634,014 $5.96 Million
Q3 2022

Oct 28, 2022

SELL
$3.43 - $5.83 $1.64 Million - $2.78 Million
-477,402 Reduced 22.8%
1,616,459 $5.82 Million
Q2 2022

Jul 25, 2022

BUY
$4.41 - $5.69 $3.07 Million - $3.96 Million
695,461 Added 49.73%
2,093,861 $11.1 Million
Q1 2022

May 13, 2022

BUY
$4.81 - $6.99 $1.71 Million - $2.49 Million
355,678 Added 34.11%
1,398,400 $7.68 Million
Q4 2021

Feb 14, 2022

BUY
$5.97 - $7.93 $2.53 Million - $3.36 Million
423,353 Added 68.35%
1,042,722 $7.1 Million
Q3 2021

Nov 15, 2021

BUY
$4.79 - $6.68 $2.88 Million - $4.01 Million
600,678 Added 3213.73%
619,369 $3.77 Million
Q2 2021

Aug 16, 2021

BUY
$5.35 - $6.35 $99,996 - $118,687
18,691 New
18,691 $528,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $280M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.